Invention Grant
- Patent Title: Substituted tetracycline compounds
- Patent Title (中): 取代四环素化合物
-
Application No.: US14281357Application Date: 2014-05-19
-
Publication No.: US09533943B2Publication Date: 2017-01-03
- Inventor: Todd Bowser , Mark Grier
- Applicant: Paratek Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: McCarter & English, LLP
- Agent Elizabeth A. Hanley
- Main IPC: A61K31/65
- IPC: A61K31/65 ; C07C237/26 ; C07C237/48 ; C07C271/22 ; C07C271/54 ; C07C275/28 ; C07C275/30
Abstract:
The present invention pertains, at least in part, to novel substituted etracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
Public/Granted literature
- US20150045329A1 SUBSTITUTED TETRACYCLINE COMPOUNDS Public/Granted day:2015-02-12
Information query
